Glenmark signs licensing deal with US firm - Livemint

Glenmark signs licensing deal with US firm
Livemint
The scrip lost 23.53% since January on slow sales growth because approvals for the firm's generic drugs in the US market were delayed and a couple of ...
Glenmark in Licensing Deal With MedicisWall Street Journal
Glenmark Generics settles litigation with MedicisEconomic Times
Glenmark outlicenses dermatology drug to Medicis PharmaMoneycontrol.com
Business Standard -Press Trust of India -India Infoline.com
all 37 news articles »